{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:29:15Z","timestamp":1789921755315,"version":"4.0.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,5]]},"DOI":"10.1093\/jnci\/djr333","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T03:12:45Z","timestamp":1314760365000},"page":"1469-1475","source":"Crossref","is-referenced-by-count":52,"title":["Menopausal Hormone Therapy and Risks of Melanoma and Nonmelanoma Skin Cancers: Women\u2019s Health Initiative Randomized Trials"],"prefix":"10.1093","volume":"103","author":[{"given":"Jean Y.","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina M.","family":"Spaunhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan T.","family":"Chlebowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Wactawski-Wende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fridtjof","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie C.","family":"Zeitouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia L.","family":"Stefanick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,8,30]]},"reference":[{"issue":"3","key":"key\n\t\t\t\t20170521020148_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","article-title":"Incidence estimate of nonmelanoma skin cancer in the United States, 2006","volume":"146","author":"Rogers","year":"2010","journal-title":"Arch Dermatol."},{"issue":"7","key":"key\n\t\t\t\t20170521020148_bib2","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":"Increasing burden of melanoma in the United States","volume":"129","author":"Linos","year":"2009","journal-title":"J Invest Dermatol."},{"issue":"1","key":"key\n\t\t\t\t20170521020148_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2004.10.016","article-title":"Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer."},{"issue":"11","key":"key\n\t\t\t\t20170521020148_bib4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/bjc.1996.275","article-title":"The multicentre south European study \u2019Helios\u2019. II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin","volume":"73","author":"Rosso","year":"1996","journal-title":"Br J Cancer."},{"issue":"11","key":"key\n\t\t\t\t20170521020148_bib5","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1096\/fj.03-1088fje","article-title":"Estradiol induces proliferation of keratinocytes via receptor-mediated mechanisms","volume":"18","author":"Verdier-Sevrain","year":"2004","journal-title":"FASEB J."},{"issue":"1","key":"key\n\t\t\t\t20170521020148_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2009.02.016","article-title":"Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled phase III trial","volume":"80","author":"Plewig","year":"2009","journal-title":"Contraception."},{"issue":"3","key":"key\n\t\t\t\t20170521020148_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jaad.2008.05.009","article-title":"Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women","volume":"59","author":"Phillips","year":"2008","journal-title":"J Am Acad Dermatol."},{"issue":"12","key":"key\n\t\t\t\t20170521020148_bib8","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1038\/jid.2009.168","article-title":"Oral contraceptives: a risk factor for squamous cell carcinoma?","volume":"129","author":"Applebaum","year":"2009","journal-title":"J Invest Dermatol."},{"issue":"2","key":"key\n\t\t\t\t20170521020148_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/ijerph7020427","article-title":"Potential risk factors for cutaneous squamous cell carcinoma include oral contraceptives: results of a nested case-control study","volume":"7","author":"Asgari","year":"2010","journal-title":"Int J Environ Res Public Health."},{"issue":"3","key":"key\n\t\t\t\t20170521020148_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clindermatol.2010.04.003","article-title":"Do hormones influence melanoma? Facts and controversies","volume":"28","author":"Gupta","year":"2010","journal-title":"Clin Dermatol."},{"issue":"1","key":"key\n\t\t\t\t20170521020148_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0738-081X(96)00117-4","article-title":"Cutaneous complications of hormonal replacement therapy","volume":"15","author":"Mor","year":"1997","journal-title":"Clin Dermatol."},{"issue":"3","key":"key\n\t\t\t\t20170521020148_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/annonc\/mdm498","article-title":"Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site","volume":"19","author":"de Vries","year":"2008","journal-title":"Ann Oncol."},{"issue":"7","key":"key\n\t\t\t\t20170521020148_bib13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjc.6600196","article-title":"A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use","volume":"86","author":"Karagas","year":"2002","journal-title":"Br J Cancer."},{"issue":"12","key":"key\n\t\t\t\t20170521020148_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1600-0625.2006.00502.x","article-title":"Oestrogen receptor-beta expression in melanocytic lesions","volume":"15","author":"Schmidt","year":"2006","journal-title":"Exp Dermatol."},{"issue":"8","key":"key\n\t\t\t\t20170521020148_bib15","first-page":"661","article-title":"Cutaneous melanoma in women: ovulatory life, menopause, and use of exogenous estrogens","volume":"3","author":"Holly","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"5","key":"key\n\t\t\t\t20170521020148_bib16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ijc.2910440515","article-title":"Risk of cancer in women receiving hormone replacement therapy","volume":"44","author":"Adami","year":"1989","journal-title":"Int J Cancer."},{"issue":"2","key":"key\n\t\t\t\t20170521020148_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/annonc\/mdn589","article-title":"Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study","volume":"20","author":"Koomen","year":"2009","journal-title":"Ann Oncol."},{"issue":"3","key":"key\n\t\t\t\t20170521020148_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women\u2019s Health Initiative Investigators","year":"2002","journal-title":"JAMA."},{"issue":"1","key":"key\n\t\t\t\t20170521020148_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the Women\u2019s Health Initiative Clinical Trial and Observational Study","volume":"19","author":"The Women\u2019s Health Initiative Study Group","year":"1998","journal-title":"Control Clin Trials."},{"issue":"4","key":"key\n\t\t\t\t20170521020148_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/gme.0b013e3181f43404","article-title":"Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009","volume":"18","author":"Tsai","year":"2011","journal-title":"Menopause."},{"issue":"14","key":"key\n\t\t\t\t20170521020148_bib21","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"The Women\u2019s Health Initiative Steering Committee","year":"2004","journal-title":"JAMA."},{"issue":"S9","key":"key\n\t\t\t\t20170521020148_bib22","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1047-2797(03)00048-6","article-title":"Outcomes ascertainment and adjudication methods in the Women's Health Initiative","volume":"13","author":"Curb","year":"2003","journal-title":"Ann Epidemiol"},{"issue":"6","key":"key\n\t\t\t\t20170521020148_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/bjc.1977.265","article-title":"Malignant melanoma and oral contraceptive use among women in California","volume":"36","author":"Beral","year":"1977","journal-title":"Br J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20170521020148_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/bjc.1984.236","article-title":"Oral contraceptive use and malignant melanoma in Australia","volume":"50","author":"Beral","year":"1984","journal-title":"Br J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20170521020148_bib25","first-page":"827","article-title":"Cutaneous melanoma in relation to exogenous hormones and reproductive factors","volume":"70","author":"Holly","year":"1983","journal-title":"J Natl Cancer Inst."},{"issue":"5","key":"key\n\t\t\t\t20170521020148_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bjc.1984.235","article-title":"Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors","volume":"50","author":"Holman","year":"1984","journal-title":"Br J Cancer."},{"issue":"6","key":"key\n\t\t\t\t20170521020148_bib27","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/bjc.1985.275","article-title":"Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study","volume":"52","author":"Gallagher","year":"1985","journal-title":"Br J Cancer."},{"issue":"6","key":"key\n\t\t\t\t20170521020148_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ijc.2910420603","article-title":"The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women","volume":"42","author":"Osterlind","year":"1988","journal-title":"Int J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20170521020148_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/ije\/27.5.751","article-title":"Hormonal and reproductive influences and risk of melanoma in women","volume":"27","author":"Smith","year":"1998","journal-title":"Int J Epidemiol."},{"issue":"5","key":"key\n\t\t\t\t20170521020148_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/aje\/kwk040","article-title":"Reproductive risk factors for cutaneous melanoma in women: a case-control study","volume":"165","author":"Lea","year":"2007","journal-title":"Am J Epidemiol."},{"issue":"7","key":"key\n\t\t\t\t20170521020148_bib31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.annepidem.2004.10.005","article-title":"Cutaneous malignant melanoma in women. phenotypic characteristics, sun exposure, and hormonal factors: a case\u2013control study from Italy","volume":"15","author":"Naldi","year":"2005","journal-title":"Ann Epidemiol."},{"issue":"3","key":"key\n\t\t\t\t20170521020148_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T","article-title":"Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy\u2014long-term follow-up of a Swedish cohort","volume":"67","author":"Persson","year":"1996","journal-title":"Int J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20170521020148_bib33","first-page":"981","article-title":"Influence of estrogen administration on tumor characteristics and survival in women with cutaneous melanoma","volume":"74","author":"Lederman","year":"1985","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"key\n\t\t\t\t20170521020148_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00008390-199812000-00013","article-title":"Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure","volume":"8","author":"Rosso","year":"1998","journal-title":"Melanoma Res."},{"issue":"2","key":"key\n\t\t\t\t20170521020148_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/carcin\/bgn243","article-title":"Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer","volume":"30","author":"Mancuso","year":"2009","journal-title":"Carcinogenesis."},{"issue":"2","key":"key\n\t\t\t\t20170521020148_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/adc.2005.086918","article-title":"Sun exposure and risk of melanoma","volume":"91","author":"Oliveria","year":"2005","journal-title":"Arch Dis Child."},{"issue":"6","key":"key\n\t\t\t\t20170521020148_bib37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/archderm.140.6.730","article-title":"Validity of patient self-reported history of skin cancer","volume":"140","author":"Ming","year":"2004","journal-title":"Arch Dermatol."},{"issue":"5","key":"key\n\t\t\t\t20170521020148_bib38","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/oxfordjournals.aje.a114319","article-title":"Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women","volume":"123","author":"Colditz","year":"1986","journal-title":"Am J Epidemiol."},{"issue":"13","key":"key\n\t\t\t\t20170521020148_bib39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/103\/19\/1469\/17311171\/djr333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T16:32:18Z","timestamp":1560529938000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djr333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,30]]},"references-count":39,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2011,8,30]]},"published-print":{"date-parts":[[2011,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djr333","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,30]]}}}